World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
172
Citations
131902
World Ranking
59
National Ranking
4

Best Scientists

D-Index
172
Citations
131902
World Ranking
799
National Ranking
20

Medicine

D-Index
177
Citations
141613
World Ranking
397
National Ranking
13

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2025 - Research.com Best Scientists Award
  • 2023 - Research.com Medicine in Netherlands Leader Award

Overview

Désirée van der Heijde is affiliated with Leiden University Medical Center in the Netherlands and has contributed extensively to medical research, particularly within rheumatology. Their work spans multiple subfields including genetics, pharmacology, immunology, and neurology, with a primary focus on rheumatology.

The scientist's research topics encompass:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Osteoarthritis Treatment and Mechanisms
  • Inflammatory Mediators and NSAID Effects
  • Biosimilars and Bioanalytical Methods
  • Peripheral Neuropathies and Disorders
  • Viral Infections and Immunology Research

Désirée van der Heijde has collaborated frequently with several co-authors, including:

  • Robin Christensen
  • Maarten Boers
  • Frank Buttgereit
  • Andriko Palmowski
  • Sabrina Mai Nielsen

Their publications have appeared in journals such as:

  • Annals of Internal Medicine
  • Scientific Reports
  • Lara D. Veeken
  • PharmacoEconomics
  • International Journal of Biology Pharmacy and Allied Sciences

Notable recent papers include:

  • Multivariable logistic and linear regression models for identification of clinically useful biomarkers for osteoarthritis, 2020, Scientific Reports
  • Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis, 2023, Lara D. Veeken
  • The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis: Individual Patient Data From Five Randomized Trials, 2023, Annals of Internal Medicine
  • Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal, 2021, PharmacoEconomics
  • A CASE REPORT OF OSTEOPHYTIC CHANGES IN THE CADAVER, 2022, International Journal of Biology Pharmacy and Allied Sciences

Their main field of study is medicine, with a total of 14 publications. Subfields with contributions include:

  • Rheumatology (8 publications)
  • Genetics (2 publications)
  • Pharmacology (1 publication)
  • Immunology (1 publication)
  • Neurology (1 publication)

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

    P E Lipsky;D M van der Heijde;E W St Clair;D E Furst

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

    M Rudwaleit;D van der Heijde;R Landewé;J Listing

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

    Lars Klareskog;Désirée van der Heijde;Julien P de Jager;Andrew Gough

  • The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

    M. Rudwaleit;D.M.F.M. van der Heijde;R.B.M. Landewé;N. Akkoc

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

    Maarten Boers;Arco C Verhoeven;Harry M Markusse;Mart Afj van de Laar

  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

    E William St Clair;Désirée M F M van der Heijde;Josef S Smolen;Ravinder N Maini

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    Désirée van der Heijde;Alan Kivitz;Michael H. Schiff;Joachim Sieper

  • Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

    Ernst Feldtkeller;Muhammad Asim Khan;Désirée van der Heijde;Sjef van der Linden

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

    Désirée van der Heijde;Ben Dijkmans;Piet Geusens;Joachim Sieper

  • Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

    Norihiro Nishimoto;Jun Hashimoto;Nobuyuki Miyasaka;Kazuhiko Yamamoto

  • Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

    Iain B McInnes;Philip J Mease;Bruce Kirkham;Arthur Kavanaugh

  • Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

    John C. Davis;Désirée Van Der Heijde;Jurgen Braun;Maxime Dougados

  • Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial

    Astrid Wanders;Désirée van der Heijde;Robert Landewé;Jéhan-Michel Béhier

Frequent Co-Authors

Robert Landewé
Robert Landewé University of Amsterdam
Maxime Dougados
Maxime Dougados Hôpital Cochin
Tore K. Kvien
Tore K. Kvien University of Oslo
Walter P. Maksymowych
Walter P. Maksymowych University of Alberta
Joachim Sieper
Joachim Sieper Charité - University Medicine Berlin
Annelies Boonen
Annelies Boonen Maastricht University Medical Centre
Philip J. Mease
Philip J. Mease University of Washington
Paul Emery
Paul Emery University of Leeds
Filip Van den Bosch
Filip Van den Bosch Ghent University
Josef S. Smolen
Josef S. Smolen Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medical school, there are many flexible online options to consider. Earning a nursing degree online is a popular choice for students seeking affordability and convenience. If you’re wondering what is the cheapest online college for nursing?, several accredited institutions offer quality programs at lower tuition rates.

Aspiring nurse practitioners have a range of cheap np programs to help them advance their clinical skills without incurring heavy debt. For those already holding an RN license, the cheapest rn to bsn online programs allow registered nurses to earn a bachelor’s degree in nursing at a lower cost and often on a self-paced schedule.

Nursing professionals interested in research or academic careers can pursue the cheapest phd nursing programs available online. These advanced degrees can open new doors in education, leadership, and specialized practice, making online nursing programs a practical starting point for a range of rewarding healthcare career pathways.

Best Scientists Citing Désirée van der Heijde

Trending Scientists